Funding for this research was provided by:
Sydney Catalyst Translational Cancer Research (Pilot and Seed Funding 2017)
Received: 25 November 2017
Accepted: 18 January 2018
First Online: 17 February 2018
Ethics approval and consent to participate
: Ethical approval was granted by the Sydney Local Health District Human Research Ethics Committee (Protocol No X17–0189 and HREC/17/RPAH282). Informed consent is obtained from each participant in the PEPA Trial.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.